KR970009811A - 인체 파필로마바이러스 16형 e6 단백질을 포함하는 자궁암 치료제 조성물 - Google Patents

인체 파필로마바이러스 16형 e6 단백질을 포함하는 자궁암 치료제 조성물 Download PDF

Info

Publication number
KR970009811A
KR970009811A KR1019950024888A KR19950024888A KR970009811A KR 970009811 A KR970009811 A KR 970009811A KR 1019950024888 A KR1019950024888 A KR 1019950024888A KR 19950024888 A KR19950024888 A KR 19950024888A KR 970009811 A KR970009811 A KR 970009811A
Authority
KR
South Korea
Prior art keywords
protein
human papillomavirus
papillomavirus type
uterine cancer
therapeutic composition
Prior art date
Application number
KR1019950024888A
Other languages
English (en)
Other versions
KR100207956B1 (ko
Inventor
박순희
진승원
윤희식
정노팔
정태화
강병태
Original Assignee
김은영
한국과학기술연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김은영, 한국과학기술연구원 filed Critical 김은영
Priority to KR1019950024888A priority Critical patent/KR100207956B1/ko
Publication of KR970009811A publication Critical patent/KR970009811A/ko
Application granted granted Critical
Publication of KR100207956B1 publication Critical patent/KR100207956B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C12N5/0638—Cytotoxic T lymphocytes [CTL] or lymphokine activated killer cells [LAK]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

본 발명은 인체 파필로마바이러스 16형 E6 단백질을 포함하는 자궁암 면역치료제에 관한 것으로, 인체 파필로마바이러스 16형 E6 단백질은 항원으로 사용되어 항체 반응 및 면역 반응을 유도하고 암세포 살해능을 갖는 면역 세포를 활성화시켜 암세포를 효과적으로 살해하므로 자궁암을 치료하는데 유용하게 이용될 수 있다.

Description

인체 파필로마바이러스 16형 E6 단백질을 포함하는 자궁암 치료제 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 인체 파필로마바이러스 16형 E6 단백질 및 면역증강제를 포함하는 자궁암 치료제 조성물.
  2. 제 1항에 있어서, 상기 단백질이 항원으로 사용되어 항체 반응 및 면역 반응을 유도하고 암세포 살해능을 갖는 면역 세포를 활성화시키는 것을 특징으로 하는 조성물.
  3. 진핵세포에서 인체 파필로마바이러스 16형 E6 단백질을 발현시키기 위한 발현벡터 pRCCMV/16E6.
  4. 제 3항의 발현 벡터로 형질전환된 마우스세포주 P815/16E6(KCTC0178BP).
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950024888A 1995-08-12 1995-08-12 인체 파필로마바이러스 16형 e6 단백질을 포함하는 자궁암 치료제 조성물 KR100207956B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019950024888A KR100207956B1 (ko) 1995-08-12 1995-08-12 인체 파필로마바이러스 16형 e6 단백질을 포함하는 자궁암 치료제 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950024888A KR100207956B1 (ko) 1995-08-12 1995-08-12 인체 파필로마바이러스 16형 e6 단백질을 포함하는 자궁암 치료제 조성물

Publications (2)

Publication Number Publication Date
KR970009811A true KR970009811A (ko) 1997-03-27
KR100207956B1 KR100207956B1 (ko) 1999-07-15

Family

ID=19423373

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950024888A KR100207956B1 (ko) 1995-08-12 1995-08-12 인체 파필로마바이러스 16형 e6 단백질을 포함하는 자궁암 치료제 조성물

Country Status (1)

Country Link
KR (1) KR100207956B1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102268283B1 (ko) * 2020-01-06 2021-06-22 엘지전자 주식회사 이젝터 및 이를 포함하는 흡수식 냉온수기

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104042654A (zh) * 2013-03-12 2014-09-17 江中药业股份有限公司 一种组合物在制备抗hpv保健品或药品或产品中的应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102268283B1 (ko) * 2020-01-06 2021-06-22 엘지전자 주식회사 이젝터 및 이를 포함하는 흡수식 냉온수기

Also Published As

Publication number Publication date
KR100207956B1 (ko) 1999-07-15

Similar Documents

Publication Publication Date Title
KR900013979A (ko) 사람 유두종비루스형 16의 e7 단백질상의 면역원성 영역
TR199800812T2 (xx) Uzun-dayanan kozmetik �r�nlerinin performans�n�n geli�tirilmesi i�in y�ntemler ve bile�imler.
ES2072452T3 (es) Medios cosmeticos desodorizantes.
DE69222303D1 (de) Kationisierte antikörper gegen intrazelluläre eiweisse
ES2171698T3 (es) Composiciones topicas con tacto mejorado para la piel.
ATE181921T1 (de) Chromatographische isolierung von nucleinsäuren
KR870002826A (ko) 퍼어머넌트 웨이브 용제
KR870008576A (ko) 헤어 웨이브제
NL7811559A (nl) Huidverzorgingsprodukt op basis van ethanol/water mengsels.
KR900000335A (ko) 히드록시알킬시스테인 유도체 및 이를 함유하는 거담제
KR970009811A (ko) 인체 파필로마바이러스 16형 e6 단백질을 포함하는 자궁암 치료제 조성물
FI961584A (fi) C-reaktiivisista proteiinifragmenteista johdetut oligopeptidit
SE8702734D0 (sv) Monoclonal antibodies to pseudomonas aeruginosa flagella
ES2074983T3 (es) Procedimieto para el aislamiento de proteinas de membranas basales a partir de tejidos humanos y animales.
JPS5244781A (en) Emulsion stabilizing agent
DE60209355D1 (de) Kosmetische zubereitung gegen hautfalten
BR0012704A (pt) Anticorpos antitumor, proteìnas e usos dos mesmos
KR900014578A (ko) 엽록소 피부미용 비누
KR970014747A (ko) 화장료 조성물
DE59509948D1 (de) Konjugat aus einem wirkstoff und einem nicht als körperfremd angesehenen, nativen protein
KR910000106A (ko) 발모촉진제
JPS533593A (en) Preparation of gel-forming microbial protein
KR950028760A (ko) 온천수 및 게르마늄-함유 광천수를 함유하는 화장료 조성물
KR890012643A (ko) 루신(Leucine)에 의한 생체에너지원 대체 용도
KR890012626A (ko) 해삼과 볏짚을 이용한 미용과 두발 제제액

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
J201 Request for trial against refusal decision
B701 Decision to grant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20060417

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee